Publication Name	World Journal of Diabetes
Manuscript ID	40147
Country	Japan

Received	2018-06-04 00:16
Peer-Review Started	2018-06-04 06:29
To Make the First Decision	2018-06-15 02:35
Return for Revision	2018-06-19 01:28
Revised	2018-06-20 10:34
Second Decision	2018-06-27 08:44
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2018-06-28 17:34
Articles in Press	2018-06-28 17:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-08-15 02:55
Publish the Manuscript Online	2018-08-15 07:53

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Exercise and glucagon-like peptide-1: Does exercise potentiate the effect of treatment?
Manuscript Source	Invited Manuscript
All Author List	Hidetaka Hamasaki
ORCID	Author(s) ORCID Number Hidetaka Hamasaki http://orcid.org/0000-0002-0124-597X
Funding Agency and Grant Number
Corresponding Author	Hidetaka Hamasaki, MD, PhD, Doctor, Endocrinology and Metabolism, Internal Medicine, Hamasaki Clinic, 2-21-4 Nishida, Kagoshima 890-0046, Japan. hhamasaki78@gmail.com
Key Words	Type 2 diabetes; Exercise; Glucagon-like peptide-1; Gut microbiota; Myokine
Core Tip	The impact of exercise on glucagon-like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes (T2D) remains unclear. Exercise could potentiate the effect of GLP-1 receptor agonists treatment and play a vital role in ameliorating GLP-1 resistance by improving gut microbiota dysbiosis and reducing the ectopic fat in patients with T2D.
Publish Date	2018-08-15 07:53
Citation	Hamasaki H. Exercise and glucagon-like peptide-1: Does exercise potentiate the effect of treatment? World J Diabetes 2018; 9(8): 138-140
URL	http://www.wjgnet.com/1948-9358/full/v9/i8/138.htm
DOI	http://dx.doi.org/10.4239/wjd.v9.i8.138

Full Article (PDF)	WJD-9-138.pdf
Full Article (Word)	WJD-9-138.doc
Manuscript File	40147-Review.docx
Answering Reviewers	40147-Answering reviewers.pdf
Audio Core Tip	40147-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	40147-Conflict-of-interest statement.pdf
Copyright License Agreement	40147-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	40147-Language certificate.pdf
Peer-review Report	40147-Peer-review(s).pdf
Scientific Misconduct Check	40147-Scientific misconduct check.pdf
Scientific Editor Work List	40147-Scientific editor work list.pdf